No full marketing authorisation yet for Covishield and Covaxin vaccines

Review process to continue, experts studying data submitted

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid

There is still some time till Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin get full marketing authorisation from India’s drug regulator.

According to government sources, the review process is

Also Read

Bharat Biotech injects pace into Covid-19 vaccine Covaxin supply

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

CMC Vellore calls for volunteers for Covaxin vaccine booster dose trials

What is the controversy surrounding Serum Institute's Covishield and EMA?

Serum Institute applies for full marketing authorisation of Covishield

CISF worst-hit by Covid-19 among all CAPFs due to airport duties

Covid-19 pandemic:10,307 fresh cases and 3 more deaths in Rajasthan

Covid-19 pandemic: Nashik sees 1,996 cases, active tally reaches 8,721

Bengal logs 22,645 new Covid-19 cases, 28 deaths; fatality rate 1.07%

Karnataka reports 28,723 new Covid-19 cases, 20,121 in Bengaluru

First Published: Jan 14 2022 | 8:38 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to